Pathogenicity of different rabies virus isolates and protection test in vaccinated mice

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 52, Issue 5, 2010, Pages 231-235

  Cunha, Elenice M S ^a   Nassar, Alessandra F C ^a   Lara, Maria do Carmo C S H ^a   Villalobos, Eliana C M ^a   Sato, Go ^b   Kobayashi, Yuki ^b   Shoji, Youko ^b   Itou, Takuya ^b   Sakai, Takeo ^b   Ito, Fumio H ^c  

^a INSTITUTO BIOLÓGICO   (Brazil)

^b NIHON UNIVERSITY   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Pathogenicity; Rabies virus; Vaccine

Indexed keywords

RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTIBEUS LITURATUS; ARTICLE; BAT; CONTROLLED STUDY; DOG; FEMALE; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOLOSSUS MOLOSSUS; MOUSE; NONHUMAN; NYCTINOMOPS LATICAUDATUS; RABIES; RABIES VIRUS; SPECIES DIFFERENCE; VIRUS ISOLATION; VIRUS VIRULENCE;

ANIMALS; CHIROPTERA; DOGS; FEMALE; LETHAL DOSE 50; MICE; RABIES; RABIES VACCINES; RABIES VIRUS;

EID: 78249273619     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652010000500002     Document Type: Article

References (36)

1. Arai YT, Kuzmin IV, Kameoka Y, Botvinkin A.D. New Lyssavirus genotype from the Lesser Mouse-eared Bat (Myotis blythi), Kyrghyzstan. Emerg Infect Dis. 2003;9:333-3337.
2. Badrane H, Bahloul C, Perrin P, Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol. 2001;75:3268-3276.
3. Baer GM. Evaluation of an animal rabies vaccine by use of two types of potency tests. Am J Vet Res. 1997;58:837-840.
4. Bernardi F, Nadin-Davis A, Wandeler AI, Armstrong J, Gomes AAB, Lima F, et al. Antigenic and genetic characterization of rabies viruses isolated from domestic and wild animals of Brazil identifies the hoary fox as a rabies reservoir. J Gen Virol. 2005;86:3153-3162.
5. Botvinkin AD, Poleschuk EM, Kuzmin IV, Borisova TI, Gazaryan SV, Yager P et al. Novel lyssaviruses isolated from bats in Russia. Emerg Infect Dis. 2003;9:1623-1625.
6. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine. 2005;23:4101-4109.
7. Cunha EMS, Silva LHQ, Lara MCCSH, Nassar AFC, Albas A, Sodré MM, et al. Bat rabies in the north-northwestern regions of the State of Sao Paulo -Brazil: 1997-2002. Rev Saúde Pública. 2006;40:1082-1086.
8. Dantas-Torres F, Valença C, Andrade Filho GV. First record of Desmodus rotundus in urban area from the city of Olinda, Pernambuco, Northeastern Brazil: a case report. Rev Inst Med Trop Sao Paulo. 2005;47:107-108.
9. Dietzschold B, Hooper DC. Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV). Vaccine. 1998;16:1656-1659.
10. Esbérard C. Considerações sobre o ataque de morcegos hematófagos a cães. Rev Bras Med Vet. 1999;21:219-220.
11. Esbérard C, Cifali A, Santos A, Thebas F. Ação de morcegos hematófagos no município do Rio de Janeiro. Rev Bras Med Vet. 2001;23:219-220.
12. Favoretto SR, Carrieri ML, Cunha EMS, Aguiar EAC, Silva LHQ, Sodré MM, et al. Antigenic typing of Brazilian rabies virus isolated from animals and humans, 1989-2000. Rev Inst Med Trop Sao Paulo. 2002;44:91-95.
13. Fekadu M, Shaddock JH, Sanderlin DW, Smith JS. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine. 1988;6:533-539.
14. Fooks AR, Brookes SM, Johnson N, McElhinney LM, Hutson AM. European bat lyssaviruses: an emerging zoonosis. Epidemiol Infect. 2003;131:1029-10239.
15. Habel K. Habel test for potency. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. Geneva: WHO; 1996. p. 369-373.
16. Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 2005;111:44-54.
17. ICTV/International Committee on Taxonomy of Viruses. Available from: http:/ictvonline.org/virusTaxonomy.asp? (Accessed 2010, April 14).
18. Ito M, Arai YT, Itou T, Sakai T, Ito FH, Takasaki T, et al. Genetic characterization and geographic distribution of rabies virus isolates in Brazil: identification of two reservoirs, dogs and vampire bats. Virology. 2001;284:214-222.
19. Kobayashi Y, Sato G, Shoji Y, Sato T, Itou T, Cunha EMS, et al. Molecular epidemiological analysis of bat rabies viruses in Brazil. J Vet Med Sci. 2005;67:647-652.
20. Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 2005;111:28-43.
21. Kuzmin IV, Meyer AE, Niezgoda M, Markotter W, Agwanda B, Breiman RF, et al. Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res. 2010;149:197-210.
22. Kuzmin IV, Orciari LA, Arai YT, Smith JS, Hanlon CA, Kameoka Y, et al. Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res. 2003;97:65-79.
23. Lafon M, Bourhy H, Sureau P. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine. 1988;6:362-8.
24. Lodmell DL, Smith JS, Esposito JJ, Ewalt LC. Cross-protection of mice against a global spectrum of rabies virus variants. J Virol. 1995;69:4957-4962.
25. Markotter I, Kuzmin IV, Rupprecht CE, Nel LH. Lagos bat virus virulence in mice inoculated by the peripheral route. Epidemiol Infect. 2009;137:1155-1162.
26. Mendes WS, Silva AAM, Neiva RF, Costa NM, Assis, MS, Vidigal PMO, et al. An outbreak of bat-transmitted human rabies in a village in the Brazilian Amazon. Rev Saúde Pública. 2009;43:1075-1077.
27. Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Programa de Vigilância, Controle e Profilaxia da Raiva. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/programa_vigilancia_controle_profilaxia_raiva.pdf (accessed 2010, April 19).
28. Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, Ruprecht CE, et al. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci USA. 1996;93:5653-5658.
29. Reed LJ, Müench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 1938;27:493-497.
30. Romijn PC, van der Heide R, Cattaneo CA, Silva RC, van der Poel WH. Study of lyssaviruses of bat origin as a source of rabies for other animal species in the State of Rio De Janeiro, Brazil. Am J Trop Med Hyg. 2003; 69:81-86.
31. Sato G, Itou T, Shoji Y, Miura Y, Mikami T, Ito M, et al. Genetic and phylogenetic analysis of glycoprotein of rabies virus isolated from several species in Brazil. J Vet Med Sci. 2004;66:747-753.
32. Schaefer R, Caldas E, Schmidt E, King AA, Roehe PM. First case of cat rabies in southern Brazil for 11 years. Vet Rec. 2002;150:216-217.
33. Schneider MC, Romijn PC, Uieda W, Tamayo H, Silva DF, Belotto A et al. Rabies transmitted by vampire bats to humans: an emerging zoonotic disease in Latin America? Rev Panam Salud Publica. 2009;25:260-269.
34. Shoji Y, Kobayashi Y, Sato G, Itou T, Miura Y, Mikami T, et al. Genetic characterization of rabies viruses isolated from frugivorous bat (Artibeus spp.) in Brazil. J Vet Med Sci. 2004;66:1271-1273.
35. Warrilow, D. Australian bat lyssavirus: a recently discovered new rhabdovirus. Curr Top Microbiol Immunol. 2005;292:25-44.
36. Zanetti CR, Franco MT, Vassão RC, Pereira CA, Pereira OAC. Failure of protection induced by a Brazilian vaccine against Brazilian wild rabies viruses. Arch Virol. 1998;143:1745-1756.